mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.2 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.2 |
mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.2 |
mRNA |
BCL-LZH-4 |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.2 |
mRNA |
avicin D |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.2 |
mRNA |
MS-275 |
gCSI |
pan-cancer |
AAC |
0.063 |
0.2 |
mRNA |
nintedanib |
CTRPv2 |
pan-cancer |
AAC |
0.043 |
0.2 |
mRNA |
BRD-K11533227 |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.2 |
mRNA |
BRD-K03911514 |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.2 |
mRNA |
KPT185 |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.2 |